FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3648411000001100: Solaraze 3% gel (Shire Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17514901000001111 Solaraze 3% gel (Shire Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
48474301000001117 Solaraze 3% gel (Almirall Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Solaraze 3% gel (Shire Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Solaraze 3% gel (Shire Pharmaceuticals Ltd) Is a Product containing precisely diclofenac sodium 30 milligram/1 gram conventional release cutaneous gel true Inferred relationship Existential restriction modifier
Solaraze 3% gel (Shire Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Solaraze 3% gel (Shire Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Solaraze 3% gel (Shire Pharmaceuticals Ltd) Has excipient Benzyl alcohol false Inferred relationship Existential restriction modifier
Solaraze 3% gel (Shire Pharmaceuticals Ltd) Has active ingredient Diclofenac sodium false Inferred relationship Existential restriction modifier
Solaraze 3% gel (Shire Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Solaraze 3% gel (Shire Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Solaraze 3% gel (Shire Pharmaceuticals Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Solaraze 3% gel (Shire Pharmaceuticals Ltd) Is a Solaraze true Inferred relationship Existential restriction modifier
Solaraze 3% gel (Shire Pharmaceuticals Ltd) Has specific active ingredient Diclofenac sodium true Inferred relationship Existential restriction modifier
Solaraze 3% gel (Shire Pharmaceuticals Ltd) Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Solaraze 3% gel (Shire Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Solaraze 3% gel (Shire Pharmaceuticals Ltd) 25 gram Is pack of False Solaraze 3% gel (Shire Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Solaraze 3% gel (Almirall Ltd) 50 gram Is pack of False Solaraze 3% gel (Shire Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Solaraze 3% gel (Almirall Ltd) 50 gram Has AMP True Solaraze 3% gel (Shire Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Solaraze 3% gel (Shire Pharmaceuticals Ltd) 25 gram Has AMP True Solaraze 3% gel (Shire Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Solaraze 3% gel (Almirall Ltd) 100 gram Has AMP True Solaraze 3% gel (Shire Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start